bnormalities in the cardiac sympathetic nervous (CSN) function have been documented in several heart diseases and have been directly implicated in their pathogenesis and disease progression.1 Noninvasive nuclear imaging techniques using the norepinephrine analog 123I-meta-iodobenzylguanidine (MIBG) may be employed to characterize CSN abnormalities and have demonstrated their usefulness for prognostication and risk stratification for adverse cardiac events in patients with heart failure (HF)
Understanding changes in central nervous system function after transcatheter aortic valve replacement
Silverio, AngeloWriting – Original Draft Preparation
;Galasso, GennaroSupervision
2022
Abstract
bnormalities in the cardiac sympathetic nervous (CSN) function have been documented in several heart diseases and have been directly implicated in their pathogenesis and disease progression.1 Noninvasive nuclear imaging techniques using the norepinephrine analog 123I-meta-iodobenzylguanidine (MIBG) may be employed to characterize CSN abnormalities and have demonstrated their usefulness for prognostication and risk stratification for adverse cardiac events in patients with heart failure (HF)File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
